Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01631292 · ClinicalTrials.gov registry record · NA
Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)
A NA study of Osteoporosis, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT01631292: Completed NA study of Osteoporosis, sponsored by Rutgers University.
NCT01631292 is a NA study of Osteoporosis that has completed, run by Rutgers University. The registered enrollment target is 81 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01631292, a NA study of Osteoporosis, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we will provide supplemental vitamin D in postmenopausal overweight/obese women, and hypothesize that it will not affect areal BMD, but will alter bone compartments (trabecular and cortical bone). In addition, higher vitamin D intake will increase serum 25OHD and suppress serum PTH and bone turnover during weight reduction. Secondary outcomes include the influence of vitamin D and weight loss on markers of insulin resistance and on cognitive tests of attention, learning, and memory.
Primary Outcome
BMD
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 600 IU Vitamin D3
- DIETARY_SUPPLEMENT 2000 IU Vitamin D3
- DIETARY_SUPPLEMENT 4000 IU Vitamin D3
Study Locations (1)
New Jersey
- Rutgers University- Thompson Hall - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2010-01 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
What the finished NCT01631292 record still lists
NCT01631292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 3 interventions - of which 600 IU Vitamin D3 is the first listed.
NCT01631292 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01631292 about?
NCT01631292 is a clinical study titled "Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)". In this study, we will provide supplemental vitamin D in postmenopausal overweight/obese women, and hypothesize that it will not affect areal BMD, but will alter bone compartments (trabecular and cortical bone). In addition, higher vitamin D intake will increase serum 25OHD and suppress serum PTH an...
What is the current status of trial NCT01631292?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2010-01. Estimated completion is 2019-12-30.
What conditions does trial NCT01631292 study?
This clinical trial studies the following conditions: Osteoporosis.
What interventions are being tested in trial NCT01631292?
The interventions under investigation include: 600 IU Vitamin D3 (DIETARY_SUPPLEMENT), 2000 IU Vitamin D3 (DIETARY_SUPPLEMENT), 4000 IU Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01631292?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01631292 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01631292's enrollment target sits among peer trials
81 43rd of 84 higher than 42 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
RECRUITING · NA
-
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
RECRUITING · NA
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
-
Mode of Exercise and Bone Biomarkers in Older Veterans
RECRUITING · NA
-
Synbiotic to Attenuate Resorption of the Skeleton
RECRUITING · NA
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia